眼球突出病变的磁共振成像（附19例报告）

本文报告了１９例经临床治疗和／或手术病理证实的突眼疾病的ＭＲＩ表现，并与Ｂ超、ＣＴ检查进行对比分析。作者认为ＭＲＩ较ＣＴ和Ｂ超具有更高的软组织分辨力；在确定病变部位、范围和性质方面均具有优势。     

与Graves眼病有关的眼肌自身抗原抗体的分子免疫学研究

为探讨Ｇｒａｖｅｓ眼病（ＧＯ）的发病机理，我们对新近发现的眼肌自身抗原及存在于ＧＯ患者血清的眼肌抗体进行了研究。血清取自１８例正常人、１８例活动性ＧＯ、１０例无限征的Ｇｒａｖｅｓ甲亢（ＧＨ）和３例桥本甲状腺炎（ＨＴ）患者。人眼肌膜蛋白经ＧＯ患者混合ＩｇＧ亲和层析后进行ＳＤＳ－聚丙烯酰胺凝胶电泳，显示分子量为４５、２８、５５和６４ｋＤ等蛋白条带。经正常人混合ＩｇＧ亲和层析未能显示上述结果。Ｗｅｓｔｅｒｎ印迹杂交虽然未能证实仅与患者血清作用的独特的眼肌抗原的存在，但６４ｋＤ印迹存在于６１％的ＧＯ、３０％的ＧＨ、０％的ＨＴ患者，正常人仅２２％阳性。抗６４ｋＤ阳性率ＧＯ组明显高于对照组（Ｐ＜０．０５）。眼肌抗体（ＥＭＡｂ）特别是抗６４ｋＤ抗体对于ＧＯ发病机理的作用值得进一步研究。     

131Ⅰ治疗甲亢性心脏病108例临床分析

目的探讨甲亢性心脏病的临床特征、发病相关因素及其治疗方案。方法对108例甲亢性心脏病患者给予131I治疗,对其临床资料进行回顾性分析。结果甲亢性心脏病以中、老年女性为主,心律失常以心房纤颤常见;甲状腺弥漫性肿大的甲亢患者伴发甲亢性心脏病的几率明显高于结节性肿大的患者;经131I抗甲亢治疗以后,随着甲亢的治愈,绝大多数甲亢性心脏病可以治愈。结论131I治疗甲亢性心脏病疗效好,治愈率高,是治疗甲亢心的理想方法。     

Technique for modified transantral orbital decompression for improved cosmesis in stable thyroid eye disease

Functional and aesthetic rehabilitation of exophthalmos in stable thyroid eye disease (TED) can be achieved with a variety of surgical approaches. This article illustrates modifications of the classic transantral technique to provide a graded orbital decompression and achieve improved cosmesis. A retrospective chart review was performed of stable TED patients who elected to undergo the modified transantral decompression; illustrative cases are described. This modified transantral orbital decompression allows for graded orbital decompression surgery, adding to the range of treatment options for stable TED patients.     

甲状腺相关眼病患者的眼球病理改变

甲状腺相关眼病（TAO）是一种眼眶常见的自身免疫性疾病,其发病机制尚未完全阐明。目前已有大量研究报道了TAO可累及眼球不同部位,但尚无一个系统的归纳总结。本研究将结合目前国内外研究报道,对TAO眼球各部位受累的证据进行归纳梳理,以探讨TAO患者眼球不同结构的病理改变。     

甲状腺功能亢进突眼征眼部血流动力学分析

突眼是甲状腺机能亢进的典型症状之一，探讨甲亢突眼征的眼部血流动力学变化的规律,通过采用超声对正常人和甲亢突眼征者的眼部血流分别进行监测，为甲亢突眼征的诊断和疗效评价指标提供有价值的参数，为甲亢突眼征的发病机制和眼部动脉血流动力学变化提供了合理的解释。甲状腺功能亢进突眼征视网膜中央动脉血流变化与球后生物学测值变化呈正相关，同时随时间的推移球后生物学测值变化。     

Thyrotoxic Periodic Paralysis: A Case Report and Literature Review

We describe a 37-year-old man with a 4-month history of episodic muscular weakness, involving mainly lower-limbs. Hypokalemia was documented in one episode and managed with intravenous potassium chloride. Hyperthyroidism was diagnosed 4 months after onset of attacks because of mild symptoms. The patient was subsequently diagnosed as having thyrotoxic periodic paralysis associated with Graves’ disease. Treatment with propranolol and methimazol was initiated and one year later he remains euthyroid and symptom free. Thyrotoxic periodic paralysis is a rare disorder, especially among Caucasians, but it should always be considered in patients with acute paralysis and hypokalemia, and thyroid function should be evaluated.     

颈动脉海绵窦瘘的眼部表现与血管内治疗

目的：分析颈动脉海棉窦瘘的眼部临床特点，评价血管内治疗的效果。方法：回顾分析126例经全脑血管造影证实为颈动脉海绵窦瘘患的病史、眼部表现、临床特点及进行的可脱性球囊栓塞治疗。结果：手术1次性栓塞成功112例(88．9％)，14例行2次栓塞。术后无并发症。98例视力较术前提高1～4行(国际标准视力表)。术后眼部淤血肿胀、眼球突出度均明显减轻或消失，眼球运动恢复正常，复视消失，视网膜出血吸收。眼部血管杂音全部消失，术后脑血管造影，瘘口均封闭。结论：对于颈动脉海绵窦瘘应及时治疗，尽快改善眼部淤血状态，以利于视功能恢复。血管内栓塞是目前治疗颈动脉海绵窦瘘最为理想的方法。     

Results of transantral decompression in hyperthyroid exophthalmos

For the moment, transantral orbital decompression is the best procedure for the treatment of manifest exophthalmos because it is a simple and effective method with hardly any postoperative complications. If some ocular motility disturbances do not disappear spontaneously postoperatively, they can be treated successfully by muscle surgery.We found that the postoperative reduction of exophthalmos further improved during the first year with an average of 3 mm. For this reason, it is not advisable to section the infraorbital nerve in order to obtain a better immediate reduction.We are convinced that this operation is justified for some patients with a manifest exophthalmos for cosmetic reasons only. Good preoperative photographic documentation is necessary in each case.     

妊娠合并甲状腺功能亢进性心脏病临床分析

目的:探讨妊娠合并甲状腺功能亢进性心脏病(简称甲亢性心脏病)的发病因素、对妊娠结局的影响及诊断方法。方法:回顾性分析29例妊娠合并甲亢性心脏病患者的相关临床资料。结果:妊娠合并甲状腺功能亢进症(简称甲亢)发生率为0.82%,甲亢性心脏病发病约占甲亢的22.6%;29例甲亢性心脏病中,甲亢病情未控制稳定而妊娠者26例,占整组病例的89.7%;29例患者均发生了不同类型心律失常,而心脏器质性病变16例,占整组病例的55.2%;母体各类严重并发症13例,发生率为44.8%;死胎3例,28周前终止妊娠4例,早产10例,胎儿丢失率为24.1%,早产率为34.5%。结论:孕前或孕期甲亢病情的控制是决定孕期甲亢性心脏病发生的主要因素;妊娠期甲亢性心脏病可导致母儿多种严重并发症;孕期行甲状腺和心功能监测可及时诊断甲亢性心脏病,减少不良妊娠结局。